Page last updated: 2024-09-03

desacetylnantradol and am-356

desacetylnantradol has been researched along with am-356 in 1 studies

Compound Research Comparison

Studies
(desacetylnantradol)
Trials
(desacetylnantradol)
Recent Studies (post-2010)
(desacetylnantradol)
Studies
(am-356)
Trials
(am-356)
Recent Studies (post-2010) (am-356)
1800216042

Protein Interaction Comparison

ProteinTaxonomydesacetylnantradol (IC50)am-356 (IC50)
Potassium channel subfamily K member 3Homo sapiens (human)0.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berglund, BA; Boring, DL; Howlett, AC; Lin, S; Makriyannis, A; Wilken, GH1

Other Studies

1 other study(ies) available for desacetylnantradol and am-356

ArticleYear
Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groups.
    Prostaglandins, leukotrienes, and essential fatty acids, 1998, Volume: 59, Issue:2

    Topics: Adenylyl Cyclases; Animals; Arachidonic Acids; Binding Sites; Brain; Cannabinoids; Cell Line; Cell Membrane; Endocannabinoids; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Palatine Tonsil; Phenanthridines; Polyunsaturated Alkamides; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Signal Transduction; Stereoisomerism; Thermodynamics

1998